Crossmark

Budesonide MMX versus prednisolone in mesalamine-refractory mild to moderate ulcerative colitis: a randomized controlled clinical trial

Published Online: 2025-09-08

Authors

Osman, Ashraf M.

Medhat, Mohammed A.

Kamal, Ghada M.
License Information

Text and Data Mining valid from 2025-09-08

Version of Record valid from 2025-09-08
More Information

Article History

Received: 29 April 2025

Accepted: 19 August 2025

First Online: 8 September 2025

Declarations

:

: Inapplicable.

: The authors declare no competing interests.

Document is current